Nestlé Withdraws NAN Infant Formula in Peru Due to Health Concerns

Nestlé Perú has announced a preventive recall of a specific batch of its NAN infant formula. This decision follows concerns over the potential presence of cereulide toxin, which is associated with the bacterium Bacillus cereus. The recall is limited to one batch, and there have been no reported health incidents in Peru related to this issue.

The presence of cereulide toxin can pose serious health risks, especially to infants. Nestlé's action is a precautionary measure to ensure consumer safety. The company has urged consumers who have purchased the affected batch to refrain from using the product and to return it for a refund or exchange.

While the recall impacts the Peruvian market, Nestlé has indicated that other batches and products remain unaffected. The company is collaborating with local health authorities to address the situation and prevent any potential risks to consumers.

This measure underscores the importance of maintaining rigorous safety standards in the production and distribution of infant formula. Nestlé continues to monitor the situation closely and has reaffirmed its commitment to the health and safety of its consumers.